Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum
about
Tumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune miceModulation of Schistosoma mansoni egg-induced granuloma formation: I-J restriction of T cell-mediated suppression in a chronic parasitic infection.The role of T cell sets in the rejection of a methylcholanthrene-induced sarcoma (S1509a) in syngeneic mice.I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages.Radiation-induced augmentation of the response of A/J mice to SaI tumor cells.Direct evidence for loss of human suppressor cells during active autoimmune disease.Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinomaEnhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-I-J alloantiserumRegulation of the immune response to tumor antigen.Demonstration of active tolerance in maintenance of established islet of Langerhans allografts.Regulatory mechanisms in cell-mediated immune responses. VII. Presence of I-C subregion determinants on mixed leukocyte reaction suppressor factorRegression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population.Functional analysis of T cells expressing Ia antigens. I. Demonstration of helper T-cell heterogeneity.Generation of primary cytotoxic lymphocytes against non-major histocompatibility complex antigens by anti-Ia serum plus complement-treated lymphocytes.In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A.Regulation of immune responses by I-J gene products. I. Production and characterization of anti-I-J monoclonal antibodies.Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.In vivo or in vitro treatments with anti-I-J alloantisera abolish immunity to AKR leukemia.T-T hybridoma product specifically suppresses tumor immunityStudies of T- and B-cell interactions in adult patients with combined immunodeficiencyRegulation of immune response to tumor antigen: interference with syngeneic tumor immunity by anti-IA alloantisera.Regulation of antibody heterogeneity by suppressor T cells: diminishing suppressor T cell activity increases the number of dinitrophenyl clones in mice immunized with dinitrophenyl-poly(Glu,Lys,Phe) or dinitrophenyl-poly(Glu,Lys,Ala).In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor.The role of H-2 and Ia antigens in graft-versus-host reactions (GVHR). Presence of host alloantigens on donor cells after GVHR and suppression of GVHR with an anti-Ia antiserum against hose Ia antigens.In vivo effects of antibodies to immune response gene products. II. Suppression of humoral immune responses with monoclonal anti-I-A is due to suppressor cells.Regulation of immune responses by I-J gene products. II. Presence of Both I-Jb and I-Jk suppressor factors in (nonsuppressor x nonsuppressor) F1 mice.Suppressor T cells activated in a primary in vitro response to non-major histocompatibility alloantigens.
P2860
Q34038870-6280E717-272F-4A7B-8318-98E3A515CCADQ35425701-330D8317-749D-4BCF-89D2-7BCBE712BB56Q35862987-0D28C518-1D3F-4C81-8BBC-CB9D0ACEAC10Q35863904-98A670AC-962F-4ED5-ABF0-19FE5367F9BAQ35885002-18CAFF87-6FE5-44A4-80B3-E4645699EF35Q35996534-4B7BAE0D-97E2-41DB-9C89-EBF3C32D5645Q36045738-EABE87DA-AA2E-4EF0-B9E6-DE4F76BA475CQ36058749-47BBA841-9C58-4B2E-A501-70FD50F43C29Q36092841-8FB7047A-FC5E-4B14-9160-39CCCB35CEFBQ36302539-B40D2893-8E92-4D45-9421-45D825E94BB9Q36341048-8C67E0FB-5FD8-460A-B4F7-C29F3A64B12BQ36341857-22847E82-66A8-412E-84B1-1EAE1B241453Q36343076-F73D149B-5D2C-4062-9F22-47024F8687C4Q36343577-20F1E7A1-F960-4446-A71D-90754E0075E9Q36345809-2CED3F94-CD71-4ADB-B783-3119A87DFC29Q36345927-DDEA91BA-C20D-4C84-9F57-C6A9EE67D14DQ36349001-3FF6FE40-AADF-47E0-9E4D-D6CC1EA1917AQ36364670-7C2FBA68-DA07-461E-8BD1-D058540989DDQ36389913-CFD7D6E9-0BA9-40B1-B84C-03D601558032Q37020415-3E3B3219-167C-4D8A-B4F2-BF5784BEF15BQ37316546-4F419B74-6514-41C8-9025-FC8964C6E56CQ37588994-4F3DEEBA-829E-44AF-BE2F-35C7DF9AB074Q37610782-463E0632-6DCC-46A1-81A7-85D07FB731ECQ39234221-B693F73B-182D-409D-9A59-482683564907Q39330732-F5817408-F1DA-47AF-8C83-72C7F6E0D514Q41881491-A0720392-861E-4B95-85EF-7BAFF2396E91Q42936361-356A0868-056A-4F3B-898E-D435F27EC750
P2860
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum
description
1977 nî lūn-bûn
@nan
1977 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum
@ast
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum
@en
type
label
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum
@ast
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum
@en
prefLabel
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum
@ast
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum
@en
P2093
P2860
P356
P1476
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum
@en
P2093
P2860
P304
P356
10.1073/PNAS.74.11.5118
P407
P577
1977-11-01T00:00:00Z